Study design and treatment
KG4/2015 was a randomised, prospective, controlled, open-labelled, multicenter, Phase III clinical trial performed at 16 Korean hospitals (ClinicalTrials.gov Identifier: NCT02854072) from November 2015 through April 2020. Figure 